Clinical trialPhase 3Completed
Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
A Randomized, Open Label Phase 3 Study of MM-398, With or Without 5-Fluorouracil and Leucovorin, Versus 5 Fluorouracil and Leucovorin in Patients With Metastatic Pancreatic Cancer Who Have Failed Prior Gemcitabine-based Therapy
- Outcome
- Outcome unknown
- Phase
- Phase 3
- Status
- Completed
- Study type
- Interventional
- Start
- November 2011
- Expected end
- October 2015
- Enrollment
- 417 participants
- Sites
- 79
- Primary outcomes
- Overall Survival
- Sponsor
- Industry
- Results posted
- 2016-02-12
- Last update
- 17 June 2016
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 7
- Builds on itEarly dose reduction/delay and the efficacy of liposomal irinotecan with fluorouracil and leucovorin in metastatic panc… DOI 10.1016/j.pan.2020.10.029↗
- Builds on itLiposomal Irinotecan + 5-FU/LV in Metastatic Pancreatic Cancer: Subgroup Analyses of Patient, Tumor, and Previous Treat… DOI 10.1097/mpa.0000000000001455↗
- Builds on itLiposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study. DOI 10.1111/cas.14264↗
- Builds on itLiposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup ana… DOI 10.1016/j.jgo.2019.02.011↗
- Builds on itNAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and cha… DOI 10.1016/j.ejca.2018.12.007↗
- Builds on itSurvival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in… DOI 10.1016/j.ejca.2018.09.010↗
- Builds on itNanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-… DOI 10.1016/s0140-6736(15)00986-1↗